Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Breast Cancer Is Associated with Increased HLA-DRB1*11:01 and HLA-DRB1*10:01 Allele Frequency in a Population of Patients from Central Italy.

Aureli A, Canossi A, Del Beato T, Buonomo O, Rossi P, Roselli M, Papola F, Marziani B, Sconocchia G.

Immunol Invest. 2020 Mar 18:1-9. doi: 10.1080/08820139.2020.1737539. [Epub ahead of print]

PMID:
32183601
2.

Tumor Infiltration by OX40+ Cells Enhances the Prognostic Significance of CD16+ Cell Infiltration in Colorectal Cancer.

Haak F, Obrecht I, Tosti N, Weixler B, Mechera R, Däster S, von Strauss M, Delko T, Spagnoli GC, Terracciano L, Sconocchia G, von Flüe M, Kraljević M, Droeser RA.

Cancer Control. 2020 Jan-Dec;27(1):1073274820903383. doi: 10.1177/1073274820903383.

3.

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism.

Arriga R, Pacifici F, Capuani B, Coppola A, Orlandi A, Scioli MG, Pastore D, Andreadi A, Sbraccia P, Tesauro M, Daniele ND, Sconocchia G, Donadel G, Bellia A, Della-Morte D, Lauro D.

Oxid Med Cell Longev. 2019 Dec 19;2019:9685607. doi: 10.1155/2019/9685607. eCollection 2019.

4.

In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.

Caratelli S, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Pastore D, Cenciarelli C, Venditti A, Del Principe MI, Lauro D, Landoni E, Du H, Savoldo B, Ferrone S, Dotti G, Sconocchia G.

Int J Cancer. 2020 Jan 1;146(1):236-247. doi: 10.1002/ijc.32663. Epub 2019 Oct 12.

PMID:
31479522
5.

CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.

Arriga R, Caratelli S, Lanzilli G, Ottaviani A, Cenciarelli C, Sconocchia T, Spagnoli GC, Iezzi G, Roselli M, Lauro D, Coppola A, Dotti G, Ferrone S, Sconocchia G.

Int J Cancer. 2020 May 1;146(9):2531-2538. doi: 10.1002/ijc.32618. Epub 2019 Aug 30.

PMID:
31396956
6.

Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes.

Marei HE, Althani A, Caceci T, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Roselli M, Caratelli S, Cenciarelli C, Sconocchia G.

Biochem Pharmacol. 2019 Aug;166:335-346. doi: 10.1016/j.bcp.2019.06.002. Epub 2019 Jun 6. Review.

PMID:
31176617
7.

Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome.

Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, Consalvo MI, Paterno G, Sarlo C, De Bellis E, Zizzari A, De Angelis G, Fraboni D, Divona M, Voso MT, Sconocchia G, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A.

Semin Hematol. 2018 Oct;55(4):209-214. doi: 10.1053/j.seminhematol.2018.02.006. Epub 2018 Feb 21. Review.

PMID:
30502849
8.

FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.

Caratelli S, Sconocchia T, Arriga R, Coppola A, Lanzilli G, Lauro D, Venditti A, Del Principe MI, Buccisano F, Maurillo L, Ferrone S, Sconocchia G.

Front Immunol. 2017 Apr 27;8:457. doi: 10.3389/fimmu.2017.00457. eCollection 2017. Review.

9.

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.

Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R, Cudillo L, De Angelis G, Sarlo C, Cefalo M, Ditto C, Di Veroli A, Mariotti B, Nasso D, De Bellis E, Del Poeta G, Voso MT, Sconocchia G, Lo Coco F, Arcese W, Amadori S, Venditti A.

Bone Marrow Transplant. 2017 Mar;52(3):473-475. doi: 10.1038/bmt.2016.308. Epub 2016 Dec 12. No abstract available.

PMID:
27941782
10.

Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.

Del Principe MI, Buccisano F, Maurillo L, Sconocchia G, Cefalo M, Consalvo MI, Sarlo C, Conti C, De Santis G, De Bellis E, Di Veroli A, Palomba P, Attrotto C, Zizzari A, Paterno G, Voso MT, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A.

Mediterr J Hematol Infect Dis. 2016 Oct 20;8(1):e2016052. eCollection 2016. Review.

11.

Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.

Canossi A, Aureli A, Del Beato T, Rossi P, Franceschilli L, De Sanctis F, Sileri P, di Lorenzo N, Buonomo O, Lauro D, Venditti A, Sconocchia G.

J Transl Med. 2016 Aug 12;14(1):239. doi: 10.1186/s12967-016-1001-y.

12.

A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.

Del Principe MI, Sarmati L, Cefalo M, Fontana C, De Santis G, Buccisano F, Maurillo L, De Bellis E, Postorino M, Sconocchia G, Del Poeta G, Sanguinetti M, Amadori S, Pagano L, Venditti A.

Mycoses. 2016 Sep;59(9):594-601. doi: 10.1111/myc.12508. Epub 2016 Apr 8. Review.

PMID:
27061932
13.

T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells.

D'Aloia MM, Caratelli S, Palumbo C, Battella S, Arriga R, Lauro D, Palmieri G, Sconocchia G, Alimandi M.

Cytotherapy. 2016 Feb;18(2):278-90. doi: 10.1016/j.jcyt.2015.10.014. Epub 2015 Dec 17.

PMID:
26705740
14.

Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damage.

Arriga R, Caratelli S, Coppola A, Spagnoli GC, Venditti A, Amadori S, Lanzilli G, Lauro D, Palomba P, Sconocchia T, Del Principe MI, Maurillo L, Buccisano F, Capuani B, Ferrone S, Sconocchia G.

Oncotarget. 2016 Jan 12;7(2):2070-9. doi: 10.18632/oncotarget.6529.

15.

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Däster S, Eppenberger-Castori S, Hirt C, Soysal SD, Delko T, Nebiker CA, Weixler B, Amicarella F, Iezzi G, Governa V, Padovan E, Mele V, Sconocchia G, Heberer M, Terracciano L, Kettelhack C, Oertli D, Spagnoli GC, von Holzen U, Tornillo L, Droeser RA.

Oncoimmunology. 2015 May 29;4(12):e1050574. eCollection 2015 Dec.

16.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

17.

SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α.

Pastore D, Della-Morte D, Coppola A, Capuani B, Lombardo MF, Pacifici F, Ferrelli F, Arriga R, Mammi C, Federici M, Bellia A, Di Daniele N, Tesauro M, Donadel G, Noto D, Sbraccia P, Sconocchia G, Lauro D.

Cell Death Dis. 2015 Sep 17;6:e1890. doi: 10.1038/cddis.2015.232.

18.

Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase.

Basello K, Pacifici F, Capuani B, Pastore D, Lombardo MF, Ferrelli F, Coppola A, Donadel G, Arriga R, Sconocchia G, Bellia A, Rogliani P, Federici M, Sbraccia P, Lauro D, Della-Morte D.

Rejuvenation Res. 2016 Feb;19(1):79-89. doi: 10.1089/rej.2015.1726.

PMID:
26230157
19.

NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma.

Coppola A, Arriga R, Lauro D, Del Principe MI, Buccisano F, Maurillo L, Palomba P, Venditti A, Sconocchia G.

Front Med (Lausanne). 2015 May 26;2:33. doi: 10.3389/fmed.2015.00033. eCollection 2015. Review.

20.

Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.

Benvenuto M, Sileri P, Rossi P, Masuelli L, Fantini M, Nanni M, Franceschilli L, Sconocchia G, Lanzilli G, Arriga R, Faggioni G, Lista F, Orlandi A, Manzari V, Gaspari AL, Modesti A, Bei R.

J Transl Med. 2015 Mar 28;13:101. doi: 10.1186/s12967-015-0455-7.

21.

Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients.

Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Sarlo C, Cefalo M, Ditto C, Di Veroli A, De Santis G, Irno Consalvo M, Fraboni D, Panetta P, Palomba P, Attrotto C, Del Poeta G, Sconocchia G, Lo-Coco F, Amadori S, Venditti A.

Ann Hematol. 2015 Aug;94(8):1319-26. doi: 10.1007/s00277-015-2364-5. Epub 2015 Apr 14.

PMID:
25869029
22.

Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.

Capuani B, Della-Morte D, Donadel G, Caratelli S, Bova L, Pastore D, De Canio M, D'Aguanno S, Coppola A, Pacifici F, Arriga R, Bellia A, Ferrelli F, Tesauro M, Federici M, Neri A, Bernardini S, Sbraccia P, Di Daniele N, Sconocchia G, Orlandi A, Urbani A, Lauro D.

Am J Physiol Endocrinol Metab. 2015 May 1;308(9):E744-55. doi: 10.1152/ajpendo.00447.2014. Epub 2015 Feb 24.

23.

NK cells and T cells cooperate during the clinical course of colorectal cancer.

Sconocchia G, Eppenberger S, Spagnoli GC, Tornillo L, Droeser R, Caratelli S, Ferrelli F, Coppola A, Arriga R, Lauro D, Iezzi G, Terracciano L, Ferrone S.

Oncoimmunology. 2014 Aug 3;3(8):e952197. eCollection 2014.

24.

High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer.

Däster S, Eppenberger-Castori S, Hirt C, Zlobec I, Delko T, Nebiker CA, Soysal SD, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Spagnoli GC, Kettelhack C, Terracciano L, Oertli D, von Holzen U, Tornillo L, Droeser RA.

Dis Markers. 2014;2014:792183. doi: 10.1155/2014/792183. Epub 2014 Dec 30.

25.

Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.

Del Principe MI, Maurillo L, Buccisano F, Sconocchia G, Cefalo M, De Santis G, Di Veroli A, Ditto C, Nasso D, Postorino M, Refrigeri M, Attrotto C, Del Poeta G, Lo-Coco F, Amadori S, Venditti A.

Mediterr J Hematol Infect Dis. 2014 Nov 1;6(1):e2014075. doi: 10.4084/MJHID.2014.075. eCollection 2014. Review.

26.

Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.

Maurillo L, Buccisano F, Piciocchi A, Del Principe MI, Sarlo C, Di Veroli A, Panetta P, Irno-Consalvo M, Nasso D, Ditto C, Refrigeri M, De Angelis G, Cerretti R, Arcese W, Sconocchia G, Lo-Coco F, Amadori S, Venditti A.

Am J Hematol. 2015 Feb;90(2):125-31. doi: 10.1002/ajh.23893. Epub 2014 Nov 24.

27.

HLA-DRB1*13:01 allele in the genetic susceptibility to colorectal carcinoma.

Aureli A, Canossi A, Del Beato T, Franceschilli L, Buonomo O, Papola F, De Sanctis F, Lanzilli G, Sileri P, Coppola A, Caratelli S, Arriga R, Orlandi A, Lauro D, Rossi P, Sconocchia G.

Int J Cancer. 2015 May 15;136(10):2464-8. doi: 10.1002/ijc.29285. Epub 2014 Oct 30.

28.

Extensive toxic epidermal necrolysis following brentuximab vedotin administration.

Del Principe MI, Sconocchia G, Buccisano F, Cefalo M, Di Veroli A, De Santis G, Nasso D, Maurillo L, Anemona L, Postorino M, Del Poeta G, Amadori S, Venditti A.

Ann Hematol. 2015 Feb;94(2):355-6. doi: 10.1007/s00277-014-2148-3. Epub 2014 Jul 2. No abstract available.

PMID:
24981690
29.

Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia.

Ferrelli F, Pastore D, Capuani B, Lombardo MF, Blot-Chabaud M, Coppola A, Basello K, Galli A, Donadel G, Romano M, Caratelli S, Pacifici F, Arriga R, Di Daniele N, Sbraccia P, Sconocchia G, Bellia A, Tesauro M, Federici M, Della-Morte D, Lauro D.

Acta Diabetol. 2015 Feb;52(1):55-64. doi: 10.1007/s00592-014-0600-4. Epub 2014 Jun 25.

PMID:
24961472
30.

Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.

Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, Lauro D.

Diabetes. 2014 Oct;63(10):3210-20. doi: 10.2337/db14-0144. Epub 2014 Jun 19.

31.

High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.

Del Principe MI, Buccisano F, Cefalo M, Maurillo L, Di Caprio L, Di Piazza F, Sarlo C, De Angelis G, Irno Consalvo M, Fraboni D, De Santis G, Ditto C, Postorino M, Sconocchia G, Del Poeta G, Amadori S, Venditti A.

Ann Hematol. 2014 Sep;93(9):1509-13. doi: 10.1007/s00277-014-2080-6. Epub 2014 Apr 22.

PMID:
24752416
32.

GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Nebiker CA, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser RA, Rosso R, Bolli M, Oertli D, von Holzen U, Adamina M, Muraro MG, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Spagnoli GC.

Clin Cancer Res. 2014 Jun 15;20(12):3094-106. doi: 10.1158/1078-0432.CCR-13-2774. Epub 2014 Apr 15.

33.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L.

Neoplasia. 2014 Jan;16(1):31-42.

34.

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis.

Hirt C, Eppenberger-Castori S, Sconocchia G, Iezzi G, Tornillo L, Terracciano L, Spagnoli GC, Droeser RA.

Oncoimmunology. 2013 Oct 1;2(10):e25990. Epub 2013 Sep 12.

35.

High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.

Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, Iezzi G, Sconocchia G, Heberer M, Lugli A, Tornillo L, Oertli D, Terracciano L, Spagnoli GC.

PLoS One. 2013 May 29;8(5):e64814. doi: 10.1371/journal.pone.0064814. Print 2013.

36.

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

Droeser RA, Hirt C, Viehl CT, Frey DM, Nebiker C, Huber X, Zlobec I, Eppenberger-Castori S, Tzankov A, Rosso R, Zuber M, Muraro MG, Amicarella F, Cremonesi E, Heberer M, Iezzi G, Lugli A, Terracciano L, Sconocchia G, Oertli D, Spagnoli GC, Tornillo L.

Eur J Cancer. 2013 Jun;49(9):2233-42. doi: 10.1016/j.ejca.2013.02.015. Epub 2013 Mar 13.

PMID:
23478000
37.

Melanoma cells inhibit NK cell functions.

Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC.

Cancer Res. 2012 Oct 15;72(20):5428-9; author reply 5430. doi: 10.1158/0008-5472.CAN-12-1181. Epub 2012 Oct 9. No abstract available.

38.

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.

Buccisano F, Maurillo L, Del Principe MI, Del Poeta G, Sconocchia G, Lo-Coco F, Arcese W, Amadori S, Venditti A.

Blood. 2012 Jan 12;119(2):332-41. doi: 10.1182/blood-2011-08-363291. Epub 2011 Oct 28. Review.

PMID:
22039260
39.

Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.

Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, Zuber M, Droeser R, Muraro MG, Mengus C, Oertli D, Ferrone S, Terracciano L, Spagnoli GC.

Int J Cancer. 2011 Jun 1;128(11):2663-72. doi: 10.1002/ijc.25609. Epub 2010 Oct 13.

40.

Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.

Sconocchia G, Spagnoli GC, Del Principe D, Ferrone S, Anselmi M, Wongsena W, Cervelli V, Schultz-Thater E, Wyler S, Carafa V, Moch H, Terracciano L, Tornillo L.

Neoplasia. 2009 Jul;11(7):662-71.

41.

Cytokine response to ischemia/reperfusion injury in an ex vivo perfused porcine liver model.

Gravante G, Ong SL, Metcalfe MS, Sorge R, Sconocchia G, Orlando G, Lloyd DM, Dennison AR.

Transplant Proc. 2009 May;41(4):1107-12. doi: 10.1016/j.transproceed.2009.02.054.

PMID:
19460492
42.

Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies.

Gravante G, Sconocchia G, Ong SL, Dennison AR, Lloyd DM.

Liver Int. 2009 Jan;29(1):18-24. doi: 10.1111/j.1478-3231.2008.01915.x. Epub 2008 Oct 30. Review.

PMID:
19018971
43.

Production and characterization of monoclonal antibodies against major histocompatibility complex class I chain-related gene A.

Wongsena W, Sconocchia G, Cho HS, Chang CC, Wang X, Klumkrathok K, Ferrone S, Leelayuwat C.

Tissue Antigens. 2008 Nov;72(5):431-40. doi: 10.1111/j.1399-0039.2008.01118.x.

44.

Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity.

Rezvani K, Price DA, Brenchley JM, Kilical Y, Gostick E, Sconocchia G, Hansmann K, Kurlander R, Douek DC, Barrett AJ.

Cytotherapy. 2007;9(3):245-51.

PMID:
17464756
45.

CD16(low/negative) tumor-infiltrating lymphocyte: lymphoid or myeloid in origin?

Sconocchia G, Del Principe D, Barrett AJ.

Clin Cancer Res. 2007 Mar 1;13(5):1620; author reply 1621. No abstract available.

46.

"Systemic apoptotic response" after thermal burns.

Gravante G, Delogu D, Sconocchia G.

Apoptosis. 2007 Feb;12(2):259-70. Review.

PMID:
17191115
47.

T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.

Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, Hou J, Curfman B, Major E, Barrett AJ.

J Gen Virol. 2006 Oct;87(Pt 10):2951-60.

PMID:
16963754
48.

Dermal apoptosis is not influenced by the severity of clinical conditions in burned patients.

Gravante G, Palmieri MB, Esposito G, Filingeri V, Delogu D, Santeusanio G, Sconocchia G, Montone A.

Eur Rev Med Pharmacol Sci. 2006 Jul-Aug;10(4):207-9. No abstract available.

PMID:
16910352
49.

More than two different bacterial species isolated from blood of toxic epidermal necrolysis patients significantly increase mortality.

Gravante G, Esposito G, Delogu D, Montone A, Sconocchia G.

Burns. 2006 Sep;32(6):793-4. Epub 2006 Aug 14. No abstract available.

PMID:
16904832
50.

Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias.

Sconocchia G, del Principe D, Barrett AJ.

Leukemia. 2006 Sep;20(9):1632-3. Epub 2006 Jun 29. No abstract available.

PMID:
16810198

Supplemental Content

Loading ...
Support Center